MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment

Journal of Experimental Medicine

Volumn 207, Issue 10, 2010, Pages 2073-2079

  Elliott, Julie M ^a   Wahle, Joseph A ^a   Yokoyama, Wayne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DEGRANULATION; INCUBATION TIME; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; TRANSPLANTATION IMMUNOLOGY;

EID: 77957724586     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100986     Document Type: Article

References (28)

1. Andersson, K.E., G.S. Williams, D.M. Davis, and P. Höglund. 2007. Quantifying the reduction in accessibility of the inhibitory NK cell receptor Ly49A caused by binding MHC class I proteins in cis. Eur. J. Immunol. 37:516-527. doi:10.1002/eji.200636693
2. Anfossi, N., P. André, S. Guia, C.S. Falk, S. Roetynck, C.A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 25:331-342. doi:10.1016/j.immuni.2006.06.013 (Pubitemid 44224147)
3. Bix, M., N.S. Liao, M. Zijlstra, J. Loring, R. Jaenisch, and D. Raulet. 1991. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature. 349:329-331. doi:10.1038/349329a0 (Pubitemid 21912075)
4. Carlin, L.M., K. Eleme, F.E. McCann, and D.M. Davis. 2001. Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses. J. Exp. Med. 194:1507-1517. doi:10.1084/jem.194.10.1507
5. Chalifour, A., L. Scarpellino, J. Back, P. Brodin, E. Devèvre, F. Gros, F. Lévy, G. Leclercq, P. Höglund, F. Beermann, and W. Held. 2009. A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity. 30:337-347. doi:10.1016/j.immuni.2008.12.019
6. Cooper, M.A., J.M. Elliott, P.A. Keyel, L. Yang, J.A. Carrero, and W.M. Yokoyama. 2009. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA. 106:1915-1919. doi:10.1073/pnas.0813192106
7. Crozat, K., K. Hoebe, S. Ugolini, N.A. Hong, E. Janssen, S. Rutschmann, S. Mudd, S. Sovath, E. Vivier, and B. Beutler. 2007. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J. Exp. Med. 204:853-863. doi:10.1084/jem.20062447
8. Cudkowicz, G., and M. Bennett. 1971. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J. Exp. Med. 134:1513-1528. doi:10.1084/jem.134.6.1513
9. Di Santo, J.P. 2006. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24:257-286. doi:10.1146/annurev. immunol.24.021605.090700
10. Fernandez, N.C., E. Treiner, R.E. Vance, A.M. Jamieson, S. Lemieux, and D.H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood. 105:4416-4423. doi:10.1182/blood-2004-08-3156
11. Grzywacz, B., J.S. Miller, and M.R. Verneris. 2008. Use of natural killer cells as immunotherapy for leukaemia. Best Pract. Res. Clin. Haematol. 21:467-483. doi:10.1016/j.beha.2008.07.008
12. Höglund, P., C. Ohlén, E. Carbone, L. Franksson, H.G. Ljunggren, A. Latour, B. Koller, and K. Kärre. 1991. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc. Natl. Acad. Sci. USA. 88:10332-10336. doi:10.1073/pnas.88.22.10332
13. Huntington, N.D., C.A. Vosshenrich, and J.P. Di Santo. 2007. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 7:703-714. doi:10.1038/nri2154
14. Joncker, N.T., and D.H. Raulet. 2008. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev. 224:85-97. doi:10.1111/j.1600-065X.2008.00658.x
15. Karlhofer, F.M., R.K. Ribaudo, and W.M. Yokoyama. 1992. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature. 358:66-70. doi:10.1038/358066a0
16. Kärre, K., H.G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319:675-678. doi:10.1038/319675a0 (Pubitemid 16119452)
17. Kåse, A., M.H. Johansson, M.Y. Olsson-Alheim, K. Kärre, and P. Höglund. 1998. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells. J. Immunol. 161:6133-6138.
18. Kelley, J., L. Walter, and J. Trowsdale. 2005. Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet. 1:129-139. doi:10.1371/journal.pgen.0010027
19. Kim, S., K. Iizuka, H.S. Kang, A. Dokun, A.R. French, S. Greco, and W.M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3:523-528. doi:10.1038/ni796
20. Kim, S., J. Poursine-Laurent, S.M. Truscott, L. Lybarger, Y.J. Song, L. Yang, A.R. French, J.B. Sunwoo, S. Lemieux, T.H. Hansen, and W.M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 436:709-713. doi:10.1038/nature03847
21. Kim, S., J.B. Sunwoo, L. Yang, T. Choi, Y.J. Song, A.R. French, A. Vlahiotis, J.F. Piccirillo, M. Cella, M. Colonna, et al. 2008. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA. 105:3053-3058. doi:10.1073/pnas.0712229105 (Pubitemid 351723666)
22. Koh, C.Y., L.A. Welniak, and W.J. Murphy. 2005. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose. Biol. Blood Marrow Transplant. 11:252-259. doi:10.1016/j.bbmt. 2005.01.006
23. Raulet, D.H., and R.E. Vance. 2006. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6:520-531. doi:10.1038/nri1863
24. Sjöström, A., M. Eriksson, C. Cerboni, M.H. Johansson, C.L. Sentman, K. Kärre, and P. Höglund. 2001. Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors. J. Exp. Med. 194:1519-1530. doi:10.1084/jem.194.10. 1519
25. Sun, J.C., and L.L. Lanier. 2008. Cutting edge: viral infection breaks NK cell tolerance to "missing self". J. Immunol. 181:7453-7457.
26. Sun, J.C., J.N. Beilke, and L.L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature. 457:557-561. doi:10.1038/nature07665
27. Yu, J., G. Heller, J. Chewning, S. Kim, W.M. Yokoyama, and K.C. Hsu. 2007. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J. Immunol. 179:5977-5989.
28. Zimmer, J., V. Ioannidis, and W. Held. 2001. H-2D ligand expression by Ly49A+ natural killer (NK) cells precludes ligand uptake from environmental cells: implications for NK cell function. J. Exp. Med. 194:1531-1539. doi:10.1084/jem.194.10.1531